Breaking the Bio-Pharma Bottleneck: How Artificial Intelligence is Reshaping the Economics, Ethics, and Execution of Drug Discovery
Executive Overview For decades, the pharmaceutical industry has operated under a sobering economic reality known as Eroom’s Law—Moore’s Law spelled backward. While technological capabilities in computing have skyrocketed, the cost of bringing a new drug to market has roughly doubled every nine years since the 1950s. Today, developing a novel therapeutic is a high-stakes, high-risk…
